Ueki Y, Vogeli B, Karagiannis A et al (2019) Ischemia and bleeding in cancer patients undergoing percutaneous coronary intervention. JACC CardioOncol 1:145–155

Article  PubMed  PubMed Central  Google Scholar 

Costa I, Andrade FTA, Carter D et al (2021) Challenges and management of acute coronary syndrome in cancer patients. Front Cardiovasc Med 8:590016

Article  CAS  PubMed  PubMed Central  Google Scholar 

Urban P, Mehran R, Colleran R et al (2019) Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the academic research consortium for high bleeding risk. Eur Heart J 40:2632–2653

Article  CAS  PubMed  PubMed Central  Google Scholar 

Campos CM, Mehran R, Capodanno D et al (2024) Risk burden of cancer in patients treated with abbreviated dual antiplatelet therapy after PCI: analysis of multicenter controlled High-Bleeding risk trials. Circ Cardiovasc Interv 17:e013000

Article  CAS  PubMed  Google Scholar 

Bharadwaj A, Potts J, Mohamed MO et al (2020) Acute myocardial infarction treatments and outcomes in 6.5 million patients with a current or historical diagnosis of cancer in the USA. Eur Heart J 41:2183–2193

Article  CAS  PubMed  Google Scholar 

Lyon AR, Lopez-Fernandez T, Couch LS et al (2022) 2022 ESC guidelines on cardio-oncology developed in collaboration with the European hematology association (EHA), the European society for therapeutic radiology and oncology (ESTRO) and the international Cardio-Oncology society (IC-OS). Eur Heart J Cardiovasc Imaging 23:e333–e465

Article  PubMed  Google Scholar 

Writing Committee M, Lawton JS, Tamis-Holland JE et al (2022) 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: executive summary: A report of the American college of cardiology/american heart association joint committee on clinical practice guidelines. J Am Coll Cardiol 79:197–215

Article  Google Scholar 

Byrne RA, Rossello X, Coughlan JJ et al (2023) 2023 ESC guidelines for the management of acute coronary syndromes. Eur Heart J 44:3720–3826

Article  CAS  PubMed  Google Scholar 

Rao SV, O’Donoghue ML, Ruel M et al (2025) 2025 ACC/AHA/ACEP/NAEMSP/SCAI guideline for the management of patients with acute coronary syndromes: A report of the American college of cardiology/american heart association joint committee on clinical practice guidelines. J Am Coll Cardiol 27:S0735-1097

Quintana RA, Monlezun DJ, Davogustto G et al (2020) Outcomes following percutaneous coronary intervention in patients with cancer. Int J Cardiol 300:106–112

Article  PubMed  Google Scholar 

Potts JE, Iliescu CA, Lopez Mattei JC et al (2019) Percutaneous coronary intervention in cancer patients: a report of the prevalence and outcomes in the united States. Eur Heart J 40:1790–1800

Article  PubMed  Google Scholar 

Urban P, Mehran R, Colleran R et al (2019) Defining high bleeding risk in patients undergoing percutaneous coronary intervention. Circulation 140:240–261

Article  PubMed  PubMed Central  Google Scholar 

Yeh ET, Tong AT, Lenihan DJ et al (2004) Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Circulation 109:3122–3131

Article  PubMed  Google Scholar 

Monlezun DJ, Lawless S, Palaskas N et al (2021) Machine Learning-Augmented propensity score analysis of percutaneous coronary intervention in over 30 million cancer and Non-cancer patients. Front Cardiovasc Med 8:620857

Article  PubMed  PubMed Central  Google Scholar 

Iannaccone M, D’Ascenzo F, Vadala P et al (2018) Prevalence and outcome of patients with cancer and acute coronary syndrome undergoing percutaneous coronary intervention: a bleemacs substudy. Eur Heart J Acute Cardiovasc Care 7:631–638

Article  PubMed  Google Scholar 

Schneider DJ, McMahon SR, Angiolillo DJ et al (2024) Platelet FcgammaRIIa as a marker of cardiovascular risk after myocardial infarction. J Am Coll Cardiol 84:1721–1729

Article  CAS  PubMed  Google Scholar 

Nobre Menezes M, Tavares da Silva M, Magalhaes A et al (2024) Interventional cardiology in cancer patients: A position paper from the Portuguese cardiovascular intervention association and the Portuguese Cardio-Oncology study group of the Portuguese society of cardiology. Rev Port Cardiol 43:35–48

Article  PubMed  Google Scholar 

Wright JR, Chauhan M, Shah C et al (2020) The TICONC (Ticagrelor-Oncology) study: implications of P2Y(12) Inhibition for metastasis and Cancer-Associated thrombosis. JACC CardioOncol 2:236–250

Article  PubMed  PubMed Central  Google Scholar 

Tjerkaski J, Jernberg T, Alfredsson J et al (2023) Comparison between Ticagrelor and clopidogrel in myocardial infarction patients with high bleeding risk. Eur Heart J Cardiovasc Pharmacother 9:627–635

Article  PubMed  PubMed Central  Google Scholar